geburtshilfe und frauenheilkunde
130190;140295
EN
DE
Home
Produkte
Zeitschriften
Bücher
Buchreihen
Service
Service für Bibliotheken
Hilfe
Kontakt
Portal
Geburtshilfe und Frauenheilkunde
Volltextsuche
Volltextsuche
Autorensuche
Titelsuche
DOI-Suche
Metadatensuche
Zeitschrift
Über diese Zeitschrift
Herausgeber
Jahresverzeichnisse
Informationen zur DFG-Nationallizenz
Impressum
Mediadaten
Autor*innen
Autorenhinweise
Manuskript einreichen
Abonnement
Ihr Abonnement: Kontakt & Information
Lizenzen: Kontaktpartner Institutionen
Stellenmarkt
Aktuelle Stellenangebote
Medizin und Markt
Medizin und Markt
nicht eingeloggt
Login
Benutzername oder E-Mail-Adresse:
Passwort:
Zugangsdaten vergessen?
Neu registrieren
OpenAthens/Shibboleth Login
Warenkorb
Jahre (Archiv)
2024
2024
2023
2022
2021
2020
2019
2018
2017
2016
2015
2014
2013
2012
2011
2010
2009
2008
2007
2006
2005
2004
2003
2002
2001
2000
1999
1998
1997
1996
1995
1994
1993
1992
1991
1990
1989
1988
1987
1986
1985
1984
1983
1982
1981
1980
Ausgaben
Aktuelle Ausgabe
Kostenlose Probeausgabe (01/2024)
Leitlinien
Alle Kurzfassungen auf einen Blick
Ähnliche Zeitschriften
TumorDiagnostik & Therapie
Frauenheilkunde up2date
Senologie - Zeitschrift für Mammadiagnostik und -therapie
RöFo - Fortschritte auf dem Gebiet der Röntgenstrahlen und der bildgebenden Verfahren
Ultraschall in der Medizin - European Journal of Ultrasound
Bücher zum Thema
Gynäkologie
Hebammenarbeit
Ratgeber: Schwangerschaft/Geburt
Ratgeber: Frauenheilkunde
Abstracts (HTML)
Autorenliste
A
B
D
E
F
G
H
J
K
L
M
N
O
P
R
S
T
V
W
Y
Aktas, B
The prognostic relevance of urokinase-type plasminogen activator (uPA) in the blood of patients with metastatic breast cancer
Aliferis, C
Significant Overall Survival Improvement In Proliferative Subtype Ovarian Cancer Patients Receiving Bevacizumab
Arnold, N
Imbalances and loss of heterozygosity (LOH) in endometrial carcinoma detected by array based Copy number variations (aCNV)
Array based Copy number variations (aCNV) are able to differ classes in endometrial carcinoma
A Disintegrin and Metalloprotease 17 (ADAM17) and its downstream signaling in chemotherapeutic resistance of ovarian cancer
Funktion des Nectin-4 bei der Entstehung von Resistenzmechanismen im Ovarialkarzinom und die Validierung als potenziell prädiktiver und prognostischer Marker
Banys-Paluchowski, M
Clinical relevance of H-RAS, K-RAS and N-RAS in a large cohort of primary breast cancer patients
The prognostic relevance of urokinase-type plasminogen activator (uPA) in the blood of patients with metastatic breast cancer
Bauerschlag, D
Imbalances and loss of heterozygosity (LOH) in endometrial carcinoma detected by array based Copy number variations (aCNV)
Array based Copy number variations (aCNV) are able to differ classes in endometrial carcinoma
Bauerschlag, DO
A Disintegrin and Metalloprotease 17 (ADAM17) and its downstream signaling in chemotherapeutic resistance of ovarian cancer
Funktion des Nectin-4 bei der Entstehung von Resistenzmechanismen im Ovarialkarzinom und die Validierung als potenziell prädiktiver und prognostischer Marker
Baum, S
Analyse und Vergleich von HPV-Genotypen in unterschiedlichen Regionen des weiblichen Anogenitaltrakts und des Hals-Rachenraums
Baumann, K
Significant Overall Survival Improvement In Proliferative Subtype Ovarian Cancer Patients Receiving Bevacizumab
Beckmann, MW
Cancers in Patients with Endometriosis
TILGen: A Program to Investigate Immune Targets in Breast Cancer Patients – First Results on the Influence of Tumor-Infiltrating Lymphocytes
Beyer, I
Identifizierung von Mutationsprofilen hereditärer BRCA1-assoziierter TNBCs
Blum, S
Cancers in Patients with Endometriosis
Bohle, R
Protein expression of SEC62 in triple-negative breast cancer
Bohle, RM
Identifikation von Prognosefaktoren beim triple-negativen Mammakarzinom
Brandl, AL
TILGen: A Program to Investigate Immune Targets in Breast Cancer Patients – First Results on the Influence of Tumor-Infiltrating Lymphocytes
Bräutigam, K
Analyse und Vergleich von HPV-Genotypen in unterschiedlichen Regionen des weiblichen Anogenitaltrakts und des Hals-Rachenraums
Breitbach, GP
Einflussfaktoren auf den Beginn einer neoadjuvanten Chemotherapie bei Mammakarzinom
Burghaus, S
Cancers in Patients with Endometriosis
de Gregorio, N
Significant Overall Survival Improvement In Proliferative Subtype Ovarian Cancer Patients Receiving Bevacizumab
Dittmer, A
Long-term exposure to carcinoma-associated fibroblasts makes breast cancer cells addictive to integrin β1
Dittmer, J
Long-term exposure to carcinoma-associated fibroblasts makes breast cancer cells addictive to integrin β1
Dowdy, SC
Significant Overall Survival Improvement In Proliferative Subtype Ovarian Cancer Patients Receiving Bevacizumab
du Bois, A
Significant Overall Survival Improvement In Proliferative Subtype Ovarian Cancer Patients Receiving Bevacizumab
Dudziak, D
TILGen: A Program to Investigate Immune Targets in Breast Cancer Patients – First Results on the Influence of Tumor-Infiltrating Lymphocytes
Erber, R
TILGen: A Program to Investigate Immune Targets in Breast Cancer Patients – First Results on the Influence of Tumor-Infiltrating Lymphocytes
Esser, K
Lead structure optimization of compounds identified to induce differentiation in solid tumors
Fasching, PA
The prognostic relevance of urokinase-type plasminogen activator (uPA) in the blood of patients with metastatic breast cancer
Cancers in Patients with Endometriosis
TILGen: A Program to Investigate Immune Targets in Breast Cancer Patients – First Results on the Influence of Tumor-Infiltrating Lymphocytes
Fehm, T
Identifizierung von Mutationsprofilen hereditärer BRCA1-assoziierter TNBCs
Clinical relevance of H-RAS, K-RAS and N-RAS in a large cohort of primary breast cancer patients
PGRMC1 interacts with proteins of the cholesterol synthesis pathway resulting in altered cholesterol metabolism in breast cancer cells
Lead structure optimization of compounds identified to induce differentiation in solid tumors
The prognostic relevance of urokinase-type plasminogen activator (uPA) in the blood of patients with metastatic breast cancer
Cancers in Patients with Endometriosis
Feuerborn, J
Funktion des Nectin-4 bei der Entstehung von Resistenzmechanismen im Ovarialkarzinom und die Validierung als potenziell prädiktiver und prognostischer Marker
Fleisch, M
Cancers in Patients with Endometriosis
Fleischer, E
Lead structure optimization of compounds identified to induce differentiation in solid tumors
Flörkemeier, I
Imbalances and loss of heterozygosity (LOH) in endometrial carcinoma detected by array based Copy number variations (aCNV)
Array based Copy number variations (aCNV) are able to differ classes in endometrial carcinoma
Fröhlich, RL
Identifizierung von Mutationsprofilen hereditärer BRCA1-assoziierter TNBCs
Füger, T
Cancers in Patients with Endometriosis
Gabriel, L
Einflussfaktoren auf den Beginn einer neoadjuvanten Chemotherapie bei Mammakarzinom
Gaß, P
TILGen: A Program to Investigate Immune Targets in Breast Cancer Patients – First Results on the Influence of Tumor-Infiltrating Lymphocytes
Germeyer, A
Cancers in Patients with Endometriosis
Häberle, L
Cancers in Patients with Endometriosis
TILGen: A Program to Investigate Immune Targets in Breast Cancer Patients – First Results on the Influence of Tumor-Infiltrating Lymphocytes
Hack, C
TILGen: A Program to Investigate Immune Targets in Breast Cancer Patients – First Results on the Influence of Tumor-Infiltrating Lymphocytes
Hamann, S
Imbalances and loss of heterozygosity (LOH) in endometrial carcinoma detected by array based Copy number variations (aCNV)
Array based Copy number variations (aCNV) are able to differ classes in endometrial carcinoma
Hartkopf, A
The prognostic relevance of urokinase-type plasminogen activator (uPA) in the blood of patients with metastatic breast cancer
Hartmann, A
TILGen: A Program to Investigate Immune Targets in Breast Cancer Patients – First Results on the Influence of Tumor-Infiltrating Lymphocytes
Hartung, CP
Cancers in Patients with Endometriosis
Hayo, C
Einflussfaktoren auf den Beginn einer neoadjuvanten Chemotherapie bei Mammakarzinom
Hedemann, N
Imbalances and loss of heterozygosity (LOH) in endometrial carcinoma detected by array based Copy number variations (aCNV)
Array based Copy number variations (aCNV) are able to differ classes in endometrial carcinoma
A Disintegrin and Metalloprotease 17 (ADAM17) and its downstream signaling in chemotherapeutic resistance of ovarian cancer
Funktion des Nectin-4 bei der Entstehung von Resistenzmechanismen im Ovarialkarzinom und die Validierung als potenziell prädiktiver und prognostischer Marker
Hein, A
Cancers in Patients with Endometriosis
TILGen: A Program to Investigate Immune Targets in Breast Cancer Patients – First Results on the Influence of Tumor-Infiltrating Lymphocytes
Heitz, F
Significant Overall Survival Improvement In Proliferative Subtype Ovarian Cancer Patients Receiving Bevacizumab
Honisch, E
Identifizierung von Mutationsprofilen hereditärer BRCA1-assoziierter TNBCs
Huebner, H
TILGen: A Program to Investigate Immune Targets in Breast Cancer Patients – First Results on the Influence of Tumor-Infiltrating Lymphocytes
Janni, W
The prognostic relevance of urokinase-type plasminogen activator (uPA) in the blood of patients with metastatic breast cancer
Jud, S
TILGen: A Program to Investigate Immune Targets in Breast Cancer Patients – First Results on the Influence of Tumor-Infiltrating Lymphocytes
Juhasz-Böss, I
Einflussfaktoren auf den Beginn einer neoadjuvanten Chemotherapie bei Mammakarzinom
Protein expression of SEC62 in triple-negative breast cancer
Identifikation von Prognosefaktoren beim triple-negativen Mammakarzinom
Juhasz-Böss, S
Einflussfaktoren auf den Beginn einer neoadjuvanten Chemotherapie bei Mammakarzinom
Karow, D
Imbalances and loss of heterozygosity (LOH) in endometrial carcinoma detected by array based Copy number variations (aCNV)
Array based Copy number variations (aCNV) are able to differ classes in endometrial carcinoma
Kasimir-Bauer, S
The prognostic relevance of urokinase-type plasminogen activator (uPA) in the blood of patients with metastatic breast cancer
Kasoha, M
Protein expression of SEC62 in triple-negative breast cancer
Identifikation von Prognosefaktoren beim triple-negativen Mammakarzinom
Kimmig, R
Significant Overall Survival Improvement In Proliferative Subtype Ovarian Cancer Patients Receiving Bevacizumab
Klinger, A
Lead structure optimization of compounds identified to induce differentiation in solid tumors
Köhrer, K
Identifizierung von Mutationsprofilen hereditärer BRCA1-assoziierter TNBCs
Kommoss, F
Significant Overall Survival Improvement In Proliferative Subtype Ovarian Cancer Patients Receiving Bevacizumab
Kommoss, S
Significant Overall Survival Improvement In Proliferative Subtype Ovarian Cancer Patients Receiving Bevacizumab
Köster, F
Analyse und Vergleich von HPV-Genotypen in unterschiedlichen Regionen des weiblichen Anogenitaltrakts und des Hals-Rachenraums
Kranich, H
TILGen: A Program to Investigate Immune Targets in Breast Cancer Patients – First Results on the Influence of Tumor-Infiltrating Lymphocytes
Kremer, AN
TILGen: A Program to Investigate Immune Targets in Breast Cancer Patients – First Results on the Influence of Tumor-Infiltrating Lymphocytes
Kulik, A
Lead structure optimization of compounds identified to induce differentiation in solid tumors
Lange, J
Cancers in Patients with Endometriosis
Langemann, H
TILGen: A Program to Investigate Immune Targets in Breast Cancer Patients – First Results on the Influence of Tumor-Infiltrating Lymphocytes
Linxweiler, M
Protein expression of SEC62 in triple-negative breast cancer
Ludescher, M
PGRMC1 interacts with proteins of the cholesterol synthesis pathway resulting in altered cholesterol metabolism in breast cancer cells
Lux, MP
TILGen: A Program to Investigate Immune Targets in Breast Cancer Patients – First Results on the Influence of Tumor-Infiltrating Lymphocytes
Ma, S
Significant Overall Survival Improvement In Proliferative Subtype Ovarian Cancer Patients Receiving Bevacizumab
Maass, N
Imbalances and loss of heterozygosity (LOH) in endometrial carcinoma detected by array based Copy number variations (aCNV)
Array based Copy number variations (aCNV) are able to differ classes in endometrial carcinoma
A Disintegrin and Metalloprotease 17 (ADAM17) and its downstream signaling in chemotherapeutic resistance of ovarian cancer
Funktion des Nectin-4 bei der Entstehung von Resistenzmechanismen im Ovarialkarzinom und die Validierung als potenziell prädiktiver und prognostischer Marker
Mackensen, A
TILGen: A Program to Investigate Immune Targets in Breast Cancer Patients – First Results on the Influence of Tumor-Infiltrating Lymphocytes
Mahner, S
Significant Overall Survival Improvement In Proliferative Subtype Ovarian Cancer Patients Receiving Bevacizumab
Maurer, J
KDM 4 Inhibition Targets Breast Cancer Stem-like Cells
Meier, S
Analyse und Vergleich von HPV-Genotypen in unterschiedlichen Regionen des weiblichen Anogenitaltrakts und des Hals-Rachenraums
Metzger, E
KDM 4 Inhibition Targets Breast Cancer Stem-like Cells
Milde-Langosch, K
Clinical relevance of H-RAS, K-RAS and N-RAS in a large cohort of primary breast cancer patients
Müller, C
Einflussfaktoren auf den Beginn einer neoadjuvanten Chemotherapie bei Mammakarzinom
Müller, V
Clinical relevance of H-RAS, K-RAS and N-RAS in a large cohort of primary breast cancer patients
The prognostic relevance of urokinase-type plasminogen activator (uPA) in the blood of patients with metastatic breast cancer
Mustea, A
Imbalances and loss of heterozygosity (LOH) in endometrial carcinoma detected by array based Copy number variations (aCNV)
Array based Copy number variations (aCNV) are able to differ classes in endometrial carcinoma
Nabieva, N
TILGen: A Program to Investigate Immune Targets in Breast Cancer Patients – First Results on the Influence of Tumor-Infiltrating Lymphocytes
Neubauer, H
PGRMC1 interacts with proteins of the cholesterol synthesis pathway resulting in altered cholesterol metabolism in breast cancer cells
Lead structure optimization of compounds identified to induce differentiation in solid tumors
Niederacher, D
Identifizierung von Mutationsprofilen hereditärer BRCA1-assoziierter TNBCs
Lead structure optimization of compounds identified to induce differentiation in solid tumors
Nusilati, A
Imbalances and loss of heterozygosity (LOH) in endometrial carcinoma detected by array based Copy number variations (aCNV)
Array based Copy number variations (aCNV) are able to differ classes in endometrial carcinoma
Oliveira-Ferrer, L
Clinical relevance of H-RAS, K-RAS and N-RAS in a large cohort of primary breast cancer patients
Oppelt, P
Cancers in Patients with Endometriosis
Pantel, K
The prognostic relevance of urokinase-type plasminogen activator (uPA) in the blood of patients with metastatic breast cancer
Park-Simon, TW
Significant Overall Survival Improvement In Proliferative Subtype Ovarian Cancer Patients Receiving Bevacizumab
Pfisterer, J
Significant Overall Survival Improvement In Proliferative Subtype Ovarian Cancer Patients Receiving Bevacizumab
Rabizadeh, S
TILGen: A Program to Investigate Immune Targets in Breast Cancer Patients – First Results on the Influence of Tumor-Infiltrating Lymphocytes
Rack, B
The prognostic relevance of urokinase-type plasminogen activator (uPA) in the blood of patients with metastatic breast cancer
Radosa, J
Einflussfaktoren auf den Beginn einer neoadjuvanten Chemotherapie bei Mammakarzinom
Protein expression of SEC62 in triple-negative breast cancer
Identifikation von Prognosefaktoren beim triple-negativen Mammakarzinom
Rauh, C
TILGen: A Program to Investigate Immune Targets in Breast Cancer Patients – First Results on the Influence of Tumor-Infiltrating Lymphocytes
Reicke, S
Cancers in Patients with Endometriosis
Renner, SP
Cancers in Patients with Endometriosis
Riethdorf, S
The prognostic relevance of urokinase-type plasminogen activator (uPA) in the blood of patients with metastatic breast cancer
Röcken, C
Imbalances and loss of heterozygosity (LOH) in endometrial carcinoma detected by array based Copy number variations (aCNV)
Array based Copy number variations (aCNV) are able to differ classes in endometrial carcinoma
Rody, A
Analyse und Vergleich von HPV-Genotypen in unterschiedlichen Regionen des weiblichen Anogenitaltrakts und des Hals-Rachenraums
Rogmans, C
A Disintegrin and Metalloprotease 17 (ADAM17) and its downstream signaling in chemotherapeutic resistance of ovarian cancer
Funktion des Nectin-4 bei der Entstehung von Resistenzmechanismen im Ovarialkarzinom und die Validierung als potenziell prädiktiver und prognostischer Marker
Rübner, M
TILGen: A Program to Investigate Immune Targets in Breast Cancer Patients – First Results on the Influence of Tumor-Infiltrating Lymphocytes
Rudelius, M
Identifizierung von Mutationsprofilen hereditärer BRCA1-assoziierter TNBCs
Scheuring, S
Identifizierung von Mutationsprofilen hereditärer BRCA1-assoziierter TNBCs
Schick, B
Protein expression of SEC62 in triple-negative breast cancer
Schippert, C
Cancers in Patients with Endometriosis
Schmalfeldt, B
Clinical relevance of H-RAS, K-RAS and N-RAS in a large cohort of primary breast cancer patients
Schmidt, G
Einflussfaktoren auf den Beginn einer neoadjuvanten Chemotherapie bei Mammakarzinom
Protein expression of SEC62 in triple-negative breast cancer
Identifikation von Prognosefaktoren beim triple-negativen Mammakarzinom
Schmidt-Arras, D
A Disintegrin and Metalloprotease 17 (ADAM17) and its downstream signaling in chemotherapeutic resistance of ovarian cancer
Schön, G
The prognostic relevance of urokinase-type plasminogen activator (uPA) in the blood of patients with metastatic breast cancer
Schroeder, W
Significant Overall Survival Improvement In Proliferative Subtype Ovarian Cancer Patients Receiving Bevacizumab
Schüle, R
KDM 4 Inhibition Targets Breast Cancer Stem-like Cells
Schulz-Wendtland, R
TILGen: A Program to Investigate Immune Targets in Breast Cancer Patients – First Results on the Influence of Tumor-Infiltrating Lymphocytes
Sebens, S
A Disintegrin and Metalloprotease 17 (ADAM17) and its downstream signaling in chemotherapeutic resistance of ovarian cancer
Sehouli, J
Significant Overall Survival Improvement In Proliferative Subtype Ovarian Cancer Patients Receiving Bevacizumab
Solomayer, EF
Einflussfaktoren auf den Beginn einer neoadjuvanten Chemotherapie bei Mammakarzinom
The prognostic relevance of urokinase-type plasminogen activator (uPA) in the blood of patients with metastatic breast cancer
Protein expression of SEC62 in triple-negative breast cancer
Identifikation von Prognosefaktoren beim triple-negativen Mammakarzinom
Stamm, N
PGRMC1 interacts with proteins of the cholesterol synthesis pathway resulting in altered cholesterol metabolism in breast cancer cells
Stepputtis, SS
KDM 4 Inhibition Targets Breast Cancer Stem-like Cells
Stickeler, E
KDM 4 Inhibition Targets Breast Cancer Stem-like Cells
Stope, MB
Imbalances and loss of heterozygosity (LOH) in endometrial carcinoma detected by array based Copy number variations (aCNV)
Array based Copy number variations (aCNV) are able to differ classes in endometrial carcinoma
Strietz, J
KDM 4 Inhibition Targets Breast Cancer Stem-like Cells
Takacs, Z
Protein expression of SEC62 in triple-negative breast cancer
Taran, FA
Significant Overall Survival Improvement In Proliferative Subtype Ovarian Cancer Patients Receiving Bevacizumab
Tchartchian, G
Cancers in Patients with Endometriosis
Tiemann, K
Imbalances and loss of heterozygosity (LOH) in endometrial carcinoma detected by array based Copy number variations (aCNV)
Array based Copy number variations (aCNV) are able to differ classes in endometrial carcinoma
Tourani, R
Significant Overall Survival Improvement In Proliferative Subtype Ovarian Cancer Patients Receiving Bevacizumab
Treeck, L
Funktion des Nectin-4 bei der Entstehung von Resistenzmechanismen im Ovarialkarzinom und die Validierung als potenziell prädiktiver und prognostischer Marker
Tribian, N
A Disintegrin and Metalloprotease 17 (ADAM17) and its downstream signaling in chemotherapeutic resistance of ovarian cancer
Vesper, AS
Identifizierung von Mutationsprofilen hereditärer BRCA1-assoziierter TNBCs
Volz, B
TILGen: A Program to Investigate Immune Targets in Breast Cancer Patients – First Results on the Influence of Tumor-Infiltrating Lymphocytes
Wang, C
Significant Overall Survival Improvement In Proliferative Subtype Ovarian Cancer Patients Receiving Bevacizumab
Wang, J
Significant Overall Survival Improvement In Proliferative Subtype Ovarian Cancer Patients Receiving Bevacizumab
Weimer, J
Imbalances and loss of heterozygosity (LOH) in endometrial carcinoma detected by array based Copy number variations (aCNV)
Array based Copy number variations (aCNV) are able to differ classes in endometrial carcinoma
A Disintegrin and Metalloprotease 17 (ADAM17) and its downstream signaling in chemotherapeutic resistance of ovarian cancer
Wesch, D
A Disintegrin and Metalloprotease 17 (ADAM17) and its downstream signaling in chemotherapeutic resistance of ovarian cancer
Widschwendter, P
Cancers in Patients with Endometriosis
Winterhoff, BJN
Significant Overall Survival Improvement In Proliferative Subtype Ovarian Cancer Patients Receiving Bevacizumab
Witzel, I
Clinical relevance of H-RAS, K-RAS and N-RAS in a large cohort of primary breast cancer patients
The prognostic relevance of urokinase-type plasminogen activator (uPA) in the blood of patients with metastatic breast cancer
Wunderle, M
TILGen: A Program to Investigate Immune Targets in Breast Cancer Patients – First Results on the Influence of Tumor-Infiltrating Lymphocytes
Yousry Youssef Yanni, C
A Disintegrin and Metalloprotease 17 (ADAM17) and its downstream signaling in chemotherapeutic resistance of ovarian cancer
Funktion des Nectin-4 bei der Entstehung von Resistenzmechanismen im Ovarialkarzinom und die Validierung als potenziell prädiktiver und prognostischer Marker